MARSHALL WACE, LLP: ECL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on ECL, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 30,770 ECL shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 30,770 sharesChange vs previous 13F -110,236 shares
0.01% of the 13F portfolio, value $8,448,827.
13F-HR 0001318757-26-000012 filed by MARSHALL WACE, LLP
Accepted , ingested - period ended2026-06-3013F 141,006 sharesChange vs previous 13F +141,006 shares
0.03% of the 13F portfolio, value $39,285,682.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 0 sharesChange vs previous 13F -100,000 shares
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-06-3013F 100,000 sharesChange vs previous 13F -422,712 shares
0.03% of the 13F portfolio, value $26,944,000.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 522,712 sharesChange vs previous 13F -261,270 shares
0.18% of the 13F portfolio, value $132,517,947.
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 783,982 sharesChange vs previous 13F not available
0.23% of the 13F portfolio, value $183,702,662.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).